Compare TRS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRS | PRGO |
|---|---|---|
| Founded | 1986 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2004 | 2013 |
| Metric | TRS | PRGO |
|---|---|---|
| Price | $41.37 | $11.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $41.50 | $19.33 |
| AVG Volume (30 Days) | 350.1K | ★ 2.9M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | 0.44% | ★ 10.28% |
| EPS Growth | ★ 400.00 | N/A |
| EPS | ★ 21.40 | N/A |
| Revenue | ★ $645,720,000.00 | $800,000.00 |
| Revenue This Year | $5.42 | N/A |
| Revenue Next Year | $4.27 | $1.02 |
| P/E Ratio | $1.92 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.57 | $9.23 |
| 52 Week High | $43.72 | $28.44 |
| Indicator | TRS | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 59.56 | 48.70 |
| Support Level | $35.40 | $10.37 |
| Resistance Level | $41.84 | $11.85 |
| Average True Range (ATR) | 1.15 | 0.56 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 89.97 | 44.32 |
TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.